New|onset IgG autoantibodies in hospitalized patients with COVID|19

New-onset IgG autoantibodies in hospitalized patients with COVID-19

COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production.

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is associated with a wide range ...

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

Autoantibodies were identified in approximately 50% of patients, but in <15% of healthy controls. When present, autoantibodies largely targeted ...

New-onset IgG autoantibodies in hospitalized patients with COVID-19.

We conclude that SARS-CoV-2 causes development of new-onset IgG autoantibodies in a significant proportion of hospitalized COVID-19 patients and are positively ...

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

COVID-19 patients with one or more autoantibodies tended to have higher levels of antibodies against SARS-CoV-2 Nonstructural Protein 1 (NSP1) ...

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

Autoantibodies tracked with longitudinal development of IgG antibodies that recognized SARS-CoV-2 structural proteins such as S1, S2, M, N and a subset of non- ...

Prevalent and persistent new-onset autoantibodies in mild to severe ...

... hospitalized COVID-19 patients at five time points over a 16 ... New-onset IgG autoantibodies in hospitalized patients with COVID-19.

SARS-CoV-2 triggers development of new-onset IgG autoantibodies ...

Prior research has shown that about 50% of hospitalized COVID-19 patients at an academic hospital in Greece had high serum levels of ...

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

We conclude that SARS-CoV-2 causes development of new-onset IgG autoantibodies in a significant proportion of hospitalized COVID-19 patients and are positively ...

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19

AbstractCoronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), is associated with a wide range of ...

Prothrombotic autoantibodies in serum from patients hospitalized ...

Similar to IgG from patients with antiphospholipid syndrome, IgG fractions isolated from patients with COVID-19 promoted NET release from neutrophils isolated ...

Hospitalization Requiring Intensive Care Unit Due to SARS-CoV-2 ...

They assessed antibody response against five SARS-CoV-2 epitopes at 6–14 days post symptom onset in these patients. Results: Patients with ICU admissions had ...

SARS-CoV-2-IgG response is different in COVID-19 outpatients and ...

Overall positivity rate for SARS-CoV-2-IgG was 81.1 % in outpatients (irrespective of sampling before or after day 21 after onset of symptoms) but significantly ...

Severe COVID-19 tied to new-onset IgG autoantibodies - MediQuality

NEW YORK 16/09 - New research confirms emerging reports of IgG autoantibodies in patients with severe COVID-19 and demonstrates that many of these patients ...

Persistence of IgG COVID-19 antibodies: A longitudinal analysis

A total of 1,695 blood samples were collected from 585 recovered COVID-19 patients up to 9 months after SARS-CoV-2 acute infection. A blood sample was collected ...

Severe COVID-19 tied to new-onset IgG autoantibodies - MediQuality

NEW YORK 16/09 - New research confirms emerging reports of IgG autoantibodies in patients with severe COVID-19 and demonstrates that many of ...

Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Res...

Antibodies were positive after a median of 63 days (range, 46–81) following COVID-19 diagnosis in all patients. There was no significant difference between ...

Factors associated with anti-SARS-CoV-2 IgG antibody production ...

In patients with COVID-19, seroconversion of specific anti-SARS-CoV-2 IgM and IgG antibodies has been observed as early as the fourth day after symptom onset [3] ...

New-onset IgG autoantibodies in hospitalized patients with COVID-19

COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production.

The intersection of COVID-19 and autoimmunity - JCI

In the study, one of seven patients with severe COVID-19 exhibited autoantibodies against IFN-α (98). In the remaining six patients, total IgG fractions ...